Sodium Cromoglicate 2% Eye Drops

Use Sodium Cromoglicate 2% Eye Drops exactly as directed by your pharmacist, prescriber or the patient information leaflet supplied with the product.

The treatment schedule for allergic conjunctivitis is: Four times daily. Do not change the dose, frequency or duration unless advised by a clinician.

Wash your hands, tilt the head back and place the prescribed drop into the lower conjunctival sac. Avoid touching the dropper tip to the eye, lashes or skin.

Many multidose formulations contain benzalkonium chloride and have specific contact-lens restrictions. Preservative-free alternatives are available. Follow the exact product leaflet for lens use and storage after opening.

If symptoms of allergic conjunctivitis worsen, do not respond as expected or you develop a serious reaction, stop and seek appropriate clinical advice.

Sodium Cromoglicate 2% Eye Drops contains Sodium Cromoglicate 2% as the main active ingredient or treatment component.

The exact formulation, excipients, device components or inactive ingredients can vary by manufacturer and pack supplied.

Always check the patient information leaflet or product instructions supplied with your specific pack, particularly if you have known allergies or intolerances.

Brief stinging, irritation or blurred vision can occur after eye-drop application. Persistent pain, photophobia or reduced vision requires eye assessment.

Many multidose formulations contain benzalkonium chloride and have specific contact-lens restrictions. Preservative-free alternatives are available. Follow the exact product leaflet for lens use and storage after opening.

Significant eye pain, marked light sensitivity, persistent blurred or reduced vision, trauma, chemical exposure or a very red single eye requires prompt face-to-face assessment rather than routine allergy treatment.

Stop treatment and seek urgent medical help for difficulty breathing, swelling of the face, lips or tongue, collapse or another severe allergic reaction.

Use only as directed on the pack or by the pharmacist, and seek clinical review if symptoms are severe, recurrent, atypical or not improving as expected.